Adaptive Biotechnologies Corp (ADPT) — 10-Q Filings
All 10-Q filings from Adaptive Biotechnologies Corp. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Adaptive Biotechnologies Swings to Profit on Doubled Revenue
— Nov 5, 2025 Risk: medium
Adaptive Biotechnologies Corp (ADPT) reported a significant turnaround in the third quarter of 2025, achieving a net income of $9.545 million, a substantial imp -
Adaptive Bio's Q2 Revenue Dips, Net Loss Widens to $55.3M
— Aug 5, 2025 Risk: high
Adaptive Biotechnologies Corp reported total revenue of $38.9 million for the three months ended June 30, 2025, a decrease from $40.1 million in the prior-year -
Adaptive Biotech Q1 2025: Genentech Deal, Medicare Reimbursements
— May 1, 2025 Risk: medium
Adaptive Biotechnologies Corp. reported its first quarter 2025 results for the period ending March 31, 2025. The company's filing indicates ongoing activities r -
Adaptive Biotechnologies Files Q3 2024 10-Q
— Nov 7, 2024 Risk: medium
Adaptive Biotechnologies Corp. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates, includ -
Adaptive Biotechnologies Files Q2 2024 10-Q
— Aug 1, 2024 Risk: medium
Adaptive Biotechnologies Corp. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the seco -
Adaptive Biotechnologies Corp. Files 10-Q for Period Ending March 31, 2024
— May 7, 2024 Risk: medium
Adaptive Biotechnologies Corp (ADPT) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Adaptive Biotechnologies Corp. reported on its 10-Q filing for
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX